The Bone Marrow and Liver Fibrosis: Friend or Foe?

Gastroenterology

Volumn 137, Issue 4, 2009, Pages 1218-1221

  Kallis, Yiannis N ^a   Forbes, Stuart J ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN TYPE 1; SPHINGOSINE 1 PHOSPHATE; VIMENTIN; ALPHA 2(I) COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL MIGRATION; EDITORIAL; FIBROGENESIS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MACROPHAGE; MESENCHYMAL STEM CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; CELL DIFFERENTIATION; CELL MOTION; DISEASE COURSE; EXPERIMENTAL LIVER CIRRHOSIS; GENETICS; HUMAN; ITO CELL; LIVER; METABOLISM; NOTE; PATHOLOGY; PROMOTER REGION; REPORTER GENE; TIME; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL MOVEMENT; COLLAGEN; DISEASE PROGRESSION; GENES, REPORTER; HEPATIC STELLATE CELLS; HUMANS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; TIME FACTORS;

EID: 70349410295     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.08.026     Document Type: Editorial

References (25)

1. Sakaida I., Terai S., Yamamoto N., et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40 (2004) 1304-1311
2. Duffield J.S., Forbes S.J., Constandinou C.M., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115 (2005) 56-65
3. Nakamura T., Torimura T., Sakamoto M., et al. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 133 (2007) 91-107 e1
4. Harb R., Xie G., Lutzko C., Guo Y., et al. Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury. Gastroenterology (2009)
5. Gordon M.Y., Levicar N., Pai M., et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 24 (2006) 1822-1830
6. Terai S., Ishikawa T., Omori K., et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24 (2006) 2292-2298
7. Lyra A.C., Soares M.B., da Silva L.F., et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 13 (2007) 1067-1073
8. am Esch II J.S., Knoefel W.T., Klein M., et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 23 (2005) 463-470
9. Direkze N.C., Forbes S.J., Brittan M., et al. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 21 (2003) 514-520
10. Baba S., Fujii H., Hirose T., et al. Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 40 (2004) 255-260
11. di Bonzo L.V., Ferrero I., Cravanzola C., et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 57 (2008) 223-231
12. Li C., Kong Y., Wang H., et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50 (2009) 1174-1183
13. Forbes S.J., Russo F.P., Rey V., et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126 (2004) 955-963
14. Russo F.P., Alison M.R., Bigger B.W., et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130 (2006) 1807-1821
15. Kisseleva T., Uchinami H., Feirt N., et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45 (2006) 429-438
16. Miyata E., Masuya M., Yoshida S., et al. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 111 (2008) 2427-2435
17. Fujimiya T., Liu J., Kojima H., et al. Pathological roles of bone-marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver. Am J Physiol Gastrointest Liver Physiol (2009)
18. Asawa S., Saito T., Satoh A., et al. Participation of bone marrow cells in biliary fibrosis after bile duct ligation. J Gastroenterol Hepatol 22 (2007) 2001-2008
19. Higashiyama R., Moro T., Nakao S., et al. Negligible contribution of none marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137 (2009) 1459-1466
20. Bartsch K., Al-Ali H., Reinhardt A., et al. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Transplantation 87 (2009) 217-221
21. Simmons P.J., Przepiorka D., Thomas E.D., et al. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328 (1987) 429-432
22. Li C., Kong Y., Wang H., et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50 (2009) 1174-1183
23. Kuo T.K., Hung S.P., Chuang C.H., et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134 (2008) 2111-2121 2121 e1-3
24. Fang B., Shi M., Liao L., et al. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78 (2004) 83-88
25. Carvalho A.B., Quintanilha L.F., Dias J.V., et al. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 26 (2008) 1307-1314